PubMed:31343125 / 624-1103
Annnotations
GoldHamster
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T115 | 16-20 | UBERON:0003101 | denotes | male |
T116 | 16-20 | CHEBI:30780 | denotes | male |
T117 | 21-32 | D008807 | denotes | BALB/c mice |
T118 | 28-32 | PR:000005054 | denotes | mice |
T120 | 28-32 | O89094 | denotes | mice |
T123 | 84-88 | D051379 | denotes | mice |
T125 | 84-88 | 10095 | denotes | mice |
T122 | 84-88 | PR:000005054 | denotes | mice |
T124 | 84-88 | O89094 | denotes | mice |
T128 | 124-127 | GO:0044101 | denotes | CCl |
T129 | 124-127 | C565133 | denotes | CCl |
T131 | 124-128 | PR:P50230 | denotes | CCl4 |
T132 | 124-128 | PR:P13236 | denotes | CCl4 |
T133 | 124-128 | PR:000002124 | denotes | CCl4 |
T134 | 124-128 | PR:P14097 | denotes | CCl4 |
T136 | 124-128 | PR:Q90826 | denotes | CCl4 |
T135 | 124-128 | CVCL_M024 | denotes | CCl4 |
T137 | 124-128 | CHEBI:27385 | denotes | CCl4 |
T138 | 150-155 | UBERON:0002107 | denotes | liver |
T139 | 150-164 | D008103 | denotes | liver fibrosis |
T140 | 150-164 | D008103 | denotes | liver fibrosis |
T144 | 208-216 | 8783 | denotes | propolis |
T143 | 208-216 | D011429 | denotes | propolis |
T145 | 208-216 | D011429 | denotes | propolis |
T146 | 228-239 | D001835 | denotes | body weight |
T147 | 228-239 | D001835 | denotes | body weight |
T149 | 327-335 | 8783 | denotes | propolis |
T148 | 327-335 | D011429 | denotes | propolis |
T150 | 327-335 | D011429 | denotes | propolis |
PubMed_Structured_Abstracts
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T2 | 0-479 | METHODS | denotes | Three groups of male BALB/c mice (n=15/ group) were used: group 1 comprised control mice; groups 2 and 3 were injected with CCl4 for the induction of liver fibrosis. Group 3 was then orally supplemented with propolis (100 mg/kg body weight) for four weeks. Different techniques were used to monitor the antifibrotic effects of propolis, including histopathological investigations using H&E, Masson's trichrome and Sirius red staining; Western blotting; flow cytometry; and ELISA. |
Goldhamster2_Cellosaurus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T9 | 26-27 | CVCL_S361|Finite_cell_line|Mus musculus | denotes | c |
T10 | 99-104 | CVCL_B528|Embryonic_stem_cell|Homo sapiens | denotes | and 3 |
T11 | 124-128 | CVCL_M024|Cancer_cell_line|Homo sapiens | denotes | CCl4 |
Inflammaging
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T7 | 0-165 | Sentence | denotes | Three groups of male BALB/c mice (n=15/ group) were used: group 1 comprised control mice; groups 2 and 3 were injected with CCl4 for the induction of liver fibrosis. |
T8 | 166-256 | Sentence | denotes | Group 3 was then orally supplemented with propolis (100 mg/kg body weight) for four weeks. |
T9 | 257-479 | Sentence | denotes | Different techniques were used to monitor the antifibrotic effects of propolis, including histopathological investigations using H&E, Masson's trichrome and Sirius red staining; Western blotting; flow cytometry; and ELISA. |
T7 | 0-165 | Sentence | denotes | Three groups of male BALB/c mice (n=15/ group) were used: group 1 comprised control mice; groups 2 and 3 were injected with CCl4 for the induction of liver fibrosis. |
T8 | 166-256 | Sentence | denotes | Group 3 was then orally supplemented with propolis (100 mg/kg body weight) for four weeks. |
T9 | 257-479 | Sentence | denotes | Different techniques were used to monitor the antifibrotic effects of propolis, including histopathological investigations using H&E, Masson's trichrome and Sirius red staining; Western blotting; flow cytometry; and ELISA. |